Antolos, Joan L.

HRN: 17-97-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2022
CEFUROXIME 1.5GM (VIAL)
12/20/2022
12/20/2022
IVT
1.5g
LD
Preop Prophylaxis
Waiting Final Action 
12/21/2022
CEFUROXIME 1.5GM (VIAL)
12/21/2022
12/22/2022
IVT
1.5g
Q8
S/P CS
Waiting Final Action 
12/21/2022
CEFUROXIME 500MG (TAB)
12/21/2022
12/28/2022
ORAL
500mg/tab
BID
S/P Repeat LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: